SLC5A2, solute carrier family 5 member 2, 6524

N. diseases: 214; N. variants: 20
Disease: cardiac event ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0741923
Disease: cardiac event
cardiac event 		0.020 Biomarker phenotype BEFREE The mechanism by which SGLT2 inhibitors reduce cardiac events in diabetic patients remains unclear. 30552292 2019
CUI: C0741923
Disease: cardiac event
cardiac event 		0.020 Biomarker phenotype BEFREE This is a literature review of the efficacy of combined treatment with a glucagon-like peptide 1 (GLP-1) agonist and a sodium glucose cotransporter-2 (SGLT2) inhibitor in lowering glycated hemoglobin (HbA1c) level, cardiac risk, cardiac events and renal decompensation. 29623594 2018